| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:2562.)
© 2000 American Heart Association, Inc.
Editorial |
From the Department of Cardiology, Academic Hospital Maastricht, Maastricht, Netherlands.
Correspondence to Hein J.J. Wellens, Department of Cardiology, Academic Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands.
Key Words: Editorials fibrillation lung veins catheter ablation
In recent years, a wealth of new information has been published on the incidence, mechanisms, consequences, and treatment of atrial fibrillation (AF) and the effect of the arrhythmia on quality of life and costs of health care. AF is the most common cardiac arrhythmia, and like prostate cancer in men, the probability of developing AF rapidly grows when a person is past 60 years of age.
Despite all that information, our current pharmacological and nonpharmacological means to prevent or control the arrhythmia are frequently disappointing. Often, its presence has to be accepted, and measures to control the ventricular rate and to prevent thromboembolic complications have to be applied. New modes of treatment aimed at preventing the arrhythmia are therefore eagerly welcomed and investigated. In this issue of Circulation, Pappone et al1 describe such a new therapeutic approach in a selected group of patients with AF that uses a transcutaneous catheter technique directed at controlling the mechanism of the arrhythmia. What do we know about AF mechanisms, and does that knowledge help us in selecting a curative approach?
Mechanism(s) of AF
Many years ago,
Moe2 postulated that
AF was based on multiple-reentrant wavelets occurring in random order
in the atrium. That theory was subsequently confirmed by mapping atrial
activation during AF in animal and human hearts. Fibrotic changes in
the atria occurring with aging and atrial dilatation secondary to
increased stiffness of the ventricular wall or valvular disease,
ischemia, and infiltrative diseases will facilitate the development of
a substrate for those multiple-reentrant wavelets.
This article has been cited by other articles:
![]() |
J. S. Ulphani, R. Arora, J. H. Cain, R. Villuendas, S. Shen, D. Gordon, F. Inderyas, L. A. Harvey, A. Morris, J. J. Goldberger, et al. The ligament of Marshall as a parasympathetic conduit Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1629 - H1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bakir, F. P. Casselman, P. Brugada, P. Geelen, F. Wellens, I. Degrieck, F. Van Praet, Y. Vermeulen, R. De Geest, and H. Vanermen Current Strategies in the Surgical Treatment of Atrial Fibrillation: Review of the Literature and Onze Lieve Vrouw Clinic's Strategy Ann. Thorac. Surg., January 1, 2007; 83(1): 331 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Pontoppidan, J C Nielsen, S H Poulsen, P T Mortensen, A K Pedersen, H K Jensen, and P S Hansen Radiofrequency ablation of atrial fibrillation: effectiveness and safety in 102 consecutive patients Heart, December 1, 2005; 91(12): 1611 - 1612. [Full Text] [PDF] |
||||
![]() |
W. P. Beukema, A. Elvan, H. T. Sie, A. R. Ramdat Misier, and H. J.J. Wellens Successful Radiofrequency Ablation in Patients With Previous Atrial Fibrillation Results in a Significant Decrease in Left Atrial Size Circulation, October 4, 2005; 112(14): 2089 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Golovchiner, A. Mazur, A. Kogan, B. Strasberg, Y. Shapira, M. Fridman, J. Kuzniec, B. A. Vidne, and E. Raanani Atrial Flutter After Surgical Radiofrequency Ablation of the Left Atrium for Atrial Fibrillation Ann. Thorac. Surg., January 1, 2005; 79(1): 108 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pacifico and P. D. Henry Ablation for atrial fibrillation: are cures really achieved? J. Am. Coll. Cardiol., June 2, 2004; 43(11): 1940 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Lawler, F. M. Corl, and E. K. Fishman Multi-Detector Row and Volume-rendered CT of the Normal and Accessory Flow Pathways of the Thoracic Systemic and Pulmonary Veins RadioGraphics, October 1, 2002; 22(90001): S45 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology Circulation, October 23, 2001; 104(17): 2118 - 2150. [Full Text] [PDF] |
||||
![]() |
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1231 - 1265. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |